<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37555646</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1437-4315</ISSN><JournalIssue CitedMedium="Internet"><Volume>404</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Biological chemistry</Title><ISOAbbreviation>Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Intracellular spatially-targeted chemical chaperones increase native state stability of mutant SOD1 barrel.</ArticleTitle><Pagination><StartPage>909</StartPage><EndPage>930</EndPage><MedlinePgn>909-930</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1515/hsz-2023-0198</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive neurological disorder with currently no cure. Central to the cellular dysfunction associated with this fatal proteinopathy is the accumulation of unfolded/misfolded superoxide dismutase 1 (SOD1) in various subcellular locations. The molecular mechanism driving the formation of SOD1 aggregates is not fully understood but numerous studies suggest that aberrant aggregation escalates with folding instability of mutant apoSOD1. Recent advances on combining organelle-targeting therapies with the anti-aggregation capacity of chemical chaperones have successfully reduce the subcellular load of misfolded/aggregated SOD1 as well as their downstream anomalous cellular processes at low concentrations (micromolar range). Nevertheless, if such local aggregate reduction directly correlates with increased folding stability remains to be explored. To fill this gap, we synthesized and tested here the effect of 9 ER-, mitochondria- and lysosome-targeted chemical chaperones on the folding stability of truncated monomeric SOD1 (SOD1<sub>bar</sub>) mutants directed to those organelles. We found that compound ER-15 specifically increased the native state stability of ER-SOD1<sub>bar</sub>-A4V, while scaffold compound FDA-approved 4-phenylbutyric acid (PBA) decreased it. Furthermore, our results suggested that ER15 mechanism of action is distinct from that of PBA, opening new therapeutic perspectives of this novel chemical chaperone on ALS treatment.</AbstractText><CopyrightInformation>&#xa9; 2023 the author(s), published by De Gruyter, Berlin/Boston.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Sara S</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0001-6033-8853</Identifier><AffiliationInfo><Affiliation>Institute of Physical and Theoretical Chemistry, TU Braunschweig, D-38106 Braunschweig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Braunschweig Integrated Centre of Systems Biology (BRICS), D-38106 Braunschweig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gnutt</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Physical and Theoretical Chemistry, TU Braunschweig, D-38106 Braunschweig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Braunschweig Integrated Centre of Systems Biology (BRICS), D-38106 Braunschweig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Physical Chemistry II, Ruhr University, D-44780 Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azoulay-Ginsburg</LastName><ForeName>Salome</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Bar-Ilan University, Ramat-Gan 5290002, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fetahaj</LastName><ForeName>Zamira</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Physical Chemistry II, Ruhr University, D-44780 Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spurlock</LastName><ForeName>Ella</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0009-9315-3439</Identifier><AffiliationInfo><Affiliation>Institute of Physical and Theoretical Chemistry, TU Braunschweig, D-38106 Braunschweig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Braunschweig Integrated Centre of Systems Biology (BRICS), D-38106 Braunschweig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindner</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Physical and Theoretical Chemistry, TU Braunschweig, D-38106 Braunschweig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Braunschweig Integrated Centre of Systems Biology (BRICS), D-38106 Braunschweig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuz</LastName><ForeName>Damon</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Physical and Theoretical Chemistry, TU Braunschweig, D-38106 Braunschweig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Braunschweig Integrated Centre of Systems Biology (BRICS), D-38106 Braunschweig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen-Erez</LastName><ForeName>Yfat</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biotechnology Engineering, The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, P.O. Box&#xa0;653, Beer Sheva 84105, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rapaport</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biotechnology Engineering, The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, P.O. Box&#xa0;653, Beer Sheva 84105, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Israelson</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, P.O. Box&#xa0;653, Beer Sheva 84105, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gruzman</LastName><ForeName>Arie-Lev</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Bar-Ilan University, Ramat-Gan 5290002, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebbinghaus</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Physical and Theoretical Chemistry, TU Braunschweig, D-38106 Braunschweig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Braunschweig Integrated Centre of Systems Biology (BRICS), D-38106 Braunschweig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Physical Chemistry II, Ruhr University, D-44780 Bochum, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center Chemical Sciences and Sustainability, Research Alliance Ruhr, Duisburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Biol Chem</MedlineTA><NlmUniqueID>9700112</NlmUniqueID><ISSNLinking>1431-6730</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018832">Molecular Chaperones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018832" MajorTopicYN="N">Molecular Chaperones</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">chemical chaperones</Keyword><Keyword MajorTopicYN="N">organelle-targeting therapy</Keyword><Keyword MajorTopicYN="N">osmolytes</Keyword><Keyword MajorTopicYN="N">protein folding and aggregation</Keyword><Keyword MajorTopicYN="N">targeted drugs</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>12</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37555646</ArticleId><ArticleId IdType="doi">10.1515/hsz-2023-0198</ArticleId><ArticleId IdType="pii">hsz-2023-0198</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alfahel, L., Argueti-Ostrovsky, S., Barel, S., Saleh, M.A., Kahn, J., Azoulay-Ginsburg, S., Rothstein, A., Ebbinghaus, S., Gruzman, A., and Israelson, A. (2022). 4-Phenylbutyric acid (4-PBA) derivatives prevent SOD1 amyloid aggregation in&#xa0;vitro with no effect on disease progression in SOD1-ALS mice. Int. J.&#xa0;Mol. Sci. 23: 9403, https://doi.org/10.3390/ijms23169403 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23169403</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen, P.M. and Al-Chalabi, A. (2011). Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat. Rev. Neurol. 7: 603&#x2013;615, https://doi.org/10.1038/nrneurol.2011.150 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId></ArticleIdList></Reference><Reference><Citation>Auton, M. and Bolen, D.W. (2005). Predicting the energetics of osmolyte-induced protein folding/unfolding. Proc. Natl. Acad. Sci. U. S. A. 102: 15065&#x2013;15068, https://doi.org/10.1073/pnas.0507053102 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0507053102</ArticleId></ArticleIdList></Reference><Reference><Citation>Azoulay-Ginsburg, S., Di Salvio, M., Weitman, M., Afri, M., Ribeiro, S., Ebbinghaus, S., Cestra, G., and Gruzman, A. (2021). Chemical chaperones targeted to the endoplasmic reticulum (ER) and lysosome prevented neurodegeneration in a C9orf72 repeat expansion drosophila amyotrophic lateral sclerosis (ALS) model. Pharmacol. Rep. 73: 536&#x2013;550, https://doi.org/10.1007/s43440-021-00226-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-021-00226-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Azoulay-Ginsburg, S., Trobiani, L., Setini, A., Favaloro, F.L., Giorda, E., Jacob, A., Hauschner, H., Levy, L., Cestra, G., De Jaco, A., et al.. (2020). A lipophilic 4-phenylbutyric acid derivative that prevents aggregation and retention of misfolded proteins. Chem. Eur. J. 26: 1834&#x2013;1845, https://doi.org/10.1002/chem.201904292 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/chem.201904292</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai, C., Biwersi, J., Verkman, A.S., and Matthay, M.A. (1998). A mouse model to test the in&#xa0;vivo efficacy of chemical chaperones. J.&#xa0;Pharmacol. Toxicol. Methods 40: 39&#x2013;45, https://doi.org/10.1016/s1056-8719(98)00034-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1056-8719(98)00034-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Baptista, R.P., Pedersen, S., Cabrita, G.J.M., Otzen, D.E., Cabral, J.M.S., and Melo, E.P. (2008). Thermodynamics and mechanism of cutinase stabilization by trehalose. Biopolymers 89: 538&#x2013;547, https://doi.org/10.1002/bip.20926 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bip.20926</ArticleId></ArticleIdList></Reference><Reference><Citation>Belleroche, J.D., Orrell, R., and King, A. (1995). Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments. J.&#xa0;Med. Genet. 32: 841&#x2013;847, https://doi.org/10.1136/jmg.32.11.841 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.32.11.841</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat, R. and Timasheff, S.N. (1992). Steric exclusion is the principal source of the preferential hydration of proteins in the presence of polyethylene glycols. Protein Sci. 1: 1133&#x2013;1143, https://doi.org/10.1002/pro.5560010907 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.5560010907</ArticleId></ArticleIdList></Reference><Reference><Citation>Bicchi, I., Morena, F., Argentati, C., Nodari, L.R., Emiliani, C., Gelati, M., Vescovi, A.L., and Martino, S. (2021). Storage of mutant human SOD1 in non-neural cells from the type-1 amyotrophic lateral sclerosis ratG93A model correlated with the lysosomes&#x2019; dysfunction. Biomedicines 9: 1080, https://doi.org/10.3390/biomedicines9091080 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9091080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordoni, M., Pansarasa, O., Scarian, E., Cristofani, R., Leone, R., Fantini, V., Garofalo, M., Diamanti, L., Bernuzzi, S., Gagliardi, S., et al.. (2022). Lysosomes dysfunction causes mitophagy impairment in PBMCs of sporadic ALS patients. Cells 11: 1272, https://doi.org/10.3390/cells11081272 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11081272</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco, D.A., Morfini, G., Karabacak, N.M., Song, Y., Gros-Louis, F., Pasinelli, P., Goolsby, H., Fontaine, B.A., Lemay, N., McKenna-Yasek, D., et al.. (2010). Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 13: 1396&#x2013;1403, https://doi.org/10.1038/nn.2660 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotherton, T.E., Li, Y., and Glass, J.D. (2013). Cellular toxicity of mutant SOD1 protein is linked to an easily soluble, non-aggregated form in&#xa0;vitro. Neurobiol. Dis. 49: 49&#x2013;56, https://doi.org/10.1016/j.nbd.2012.08.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.08.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruening, W., Roy, J., Giasson, B., Figlewicz, D.A., Mushynski, W.E., and Durham, H.D. (1999). Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J.&#xa0;Neurochem. 72: 693&#x2013;699, https://doi.org/10.1046/j.1471-4159.1999.0720693.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1999.0720693.x</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;ning, S., Sharma, A., Vachharajani, S., Newcombe, E., Ormsby, A., Gao, M., Gnutt, D., V&#xf6;pel, T., Hatters, D.M., and Ebbinghaus, S. (2017). Conformational dynamics and self-association of intrinsically disordered Huntingtin exon 1 in cells. Phys. Chem. Chem. Phys. 19: 10738&#x2013;10747, https://doi.org/10.1039/c6cp08167c .</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c6cp08167c</ArticleId></ArticleIdList></Reference><Reference><Citation>Carreras-Sureda, A., Pih&#xe1;n, P., and Hetz, C. (2018). Calcium signaling at the endoplasmic reticulum: fine-tuning stress responses. Cell Calcium 70: 24&#x2013;31, https://doi.org/10.1016/j.ceca.2017.08.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2017.08.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Cela, I., Dufrusine, B., Rossi, C., Luini, A., De Laurenzi, V., Federici, L., and Sallese, M. (2022). KDEL receptors: pathophysiological functions, therapeutic options, and biotechnological opportunities. Biomedicines 10: 1234, https://doi.org/10.3390/biomedicines10061234 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10061234</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortez, L. and Sim, V. (2014). The therapeutic potential of chemical chaperones in protein folding diseases. Prion 8: 197&#x2013;202, https://doi.org/10.4161/pri.28938 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.28938</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino, M., Pesaresi, M.G., Amori, I., Crosio, C., Ferri, A., Nencini, M., and Carr&#xec;, M.T. (2009). Oligomerization of mutant SOD1 in mitochondria of motoneuronal cells drives mitochondrial damage and cell toxicity. Antioxi. Redox Signal. 11: 1547&#x2013;1558, https://doi.org/10.1089/ars.2009.2545 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2545</ArticleId></ArticleIdList></Reference><Reference><Citation>Culik, R.M., Sekhar, A., Nagesh, J., Deol, H., Rumfeldt, J.A.O., Meiering, E.M., and Kay, L.E. (2018). Effects of maturation on the conformational free-energy landscape of SOD1. Proc. Natl. Acad. Sci. U. S. A. 115: E2546&#x2013;E2555, https://doi.org/10.1073/pnas.1721022115 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1721022115</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielsson, J., Kurnik, M., Lang, L., and Oliveberg, M. (2011). Cutting off functional loops from homodimeric enzyme superoxide dismutase 1 (SOD1) leaves monomeric &#x3b2;-barrels. J.&#xa0;Biol. Chem. 286: 33070&#x2013;33083, https://doi.org/10.1074/jbc.m111.251223 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.m111.251223</ArticleId></ArticleIdList></Reference><Reference><Citation>Das, B., Roychowdhury, S., Mohanty, P., Rizuan, A., Chakraborty, J., Mittal, J., and Chattopadhyay, K. (2023). A Zn-dependent structural transition of SOD1 modulates its ability to undergo phase separation. EMBO J. 42: e111185, https://doi.org/10.15252/embj.2022111185 .</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2022111185</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng, H.-X., Shi, Y., Furukawa, Y., Zhai, H., Fu, R., Liu, E., Gorrie, G.H., Khan, M.S., Hung, W.-Y., Bigio, E.H., et al.. (2006). Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc. Natl. Acad. Sci. U. S. A. 103: 7142&#x2013;7147, https://doi.org/10.1073/pnas.0602046103 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0602046103</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar, A., Girdhar, K., Singh, D., Gelman, H., Ebbinghaus, S., and Gruebele, M. (2011). Protein stability and folding kinetics in the nucleus and endoplasmic reticulum of eucaryotic cells. Biophys. J. 101: 421&#x2013;430, https://doi.org/10.1016/j.bpj.2011.05.071 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2011.05.071</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebbinghaus, S., Dhar, A., McDonald, J.D., and Gruebele, M. (2010). Protein folding stability and dynamics imaged in a living cell. Nat. Methods 7: 319&#x2013;323, https://doi.org/10.1038/nmeth.1435 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1435</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekhtiari Bidhendi, E., Bergh, J., Zetterstr&#xf6;m, P., Forsberg, K., Pakkenberg, B., Andersen, P.M., Marklund, S.L., and Br&#xe4;nnstr&#xf6;m, T. (2018). Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis. Acta Neuropathol. 136: 939&#x2013;953, https://doi.org/10.1007/s00401-018-1915-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1915-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg, K., Jonsson, P.A., Andersen, P.M., Bergemalm, D., Graffmo, K.S., Hultdin, M., Jacobsson, J., Rosquist, R., Marklund, S.L., and Br&#xe4;nnstr&#xf6;m, T. (2010). Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS One 5: e11552, https://doi.org/10.1371/journal.pone.0011552 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011552</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa, Y. and O&#x2019;Halloran, T.V. (2005). Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation. J.&#xa0;Biol. Chem. 280: 17266&#x2013;17274, https://doi.org/10.1074/jbc.m500482200 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.m500482200</ArticleId></ArticleIdList></Reference><Reference><Citation>Getter, T., Zaks, I., Barhum, Y., Ben-Zur, T., B&#xf6;selt, S., Gregoire, S., Viskind, O., Shani, T., Gottlieb, H., Green, O., et al.. (2015). A chemical chaperone-based drug candidate is effective in a mouse model of amyotrophic lateral sclerosis (ALS). ChemMedChem 10: 850&#x2013;861, https://doi.org/10.1002/cmdc.201500045 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.201500045</ArticleId></ArticleIdList></Reference><Reference><Citation>Girdhar, K., Scott, G., Chemla, Y.R., and Gruebele, M. (2011). Better biomolecule thermodynamics from kinetics. J.&#xa0;Chem. Phys. 135: 015102, https://doi.org/10.1063/1.3607605 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.3607605</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnutt, D. and Ebbinghaus, S. (2016). The macromolecular crowding effect -- from in&#xa0;vitro into the cell. Biol. Chem. 397: 37&#x2013;44, https://doi.org/10.1515/hsz-2015-0161 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2015-0161</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnutt, D., Sistemich, L., and Ebbinghaus, S. (2019a). Protein folding modulation in cells subject to differentiation and stress. Front. Mol. Biosci. 6: 38, https://doi.org/10.3389/fmolb.2019.00038 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2019.00038</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnutt, D., Timr, S., Ahlers, J., K&#xf6;nig, B., Manderfeld, E., Heyden, M., Sterpone, F., and Ebbinghaus, S. (2019b). Stability effect of quinary interactions reversed by single point mutations. J.&#xa0;Am. Chem. Soc. 141: 4660&#x2013;4669, https://doi.org/10.1021/jacs.8b13025 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.8b13025</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb, H.E., Kotlyar, V., and Nudelman, A. (1997). NMR chemical shifts of common laboratory solvents as trace impurities. J.&#xa0;Org. Chem. 62: 7512&#x2013;7515, https://doi.org/10.1021/jo971176v .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jo971176v</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad, L.I., Guest, W.C., Yanai, A., Pokrishevsky, E., O&#x2019;Neill, M.A., Gibbs, E., Semenchenko, V., Yousefi, M., Wishart, D.S., Plotkin, S.S., et al.. (2011). Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc. Natl. Acad. Sci. U. S. A. 108: 16398&#x2013;16403, https://doi.org/10.1073/pnas.1102645108 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102645108</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad, L.I., Yerbury, J.J., Turner, B.J., Guest, W.C., Pokrishevsky, E., O&#x2019;Neill, M.A., Yanai, A., Silverman, J.M., Zeineddine, R., Corcoran, L., et al.. (2014). Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. U. S. A. 111: 3620&#x2013;3625, https://doi.org/10.1073/pnas.1312245111 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId></ArticleIdList></Reference><Reference><Citation>Guinn, E.J., Pegram, L.M., Capp, M.W., Pollock, M.N., and Record, M.T. (2011). Quantifying why urea is a protein denaturant, whereas glycine betaine is a protein stabilizer. Proc. Natl. Acad. Sci. U. S. A. 108: 16932&#x2013;16937, https://doi.org/10.1073/pnas.1109372108 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1109372108</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, Y.H., Moon, H.J., You, B.R., and Park, W.H. (2009). The effect of MG132, a proteasome inhibitor on HeLa cells in relation to cell growth, reactive oxygen species and GSH. Oncol. Rep. 22: 215&#x2013;221.</Citation></Reference><Reference><Citation>Hinchcliffe, M. and Smith, A. (2017). Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis. Degener. Neurol. Neuromuscul. Dis. 7: 61&#x2013;70, https://doi.org/10.2147/dnnd.s135748 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/dnnd.s135748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignatova, Z. and Gierasch, L.M. (2006). Inhibition of protein aggregation in&#xa0;vitro and in&#xa0;vivo by a natural osmoprotectant. Proc. Natl. Acad. Sci. U. S. A. 103: 13357&#x2013;13361, https://doi.org/10.1073/pnas.0603772103 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0603772103</ArticleId></ArticleIdList></Reference><Reference><Citation>Jameson, V.J.A., Cochem&#xe9;, H.M., Logan, A., Hanton, L.R., Smith, R.A.J., and Murphy, M.P. (2015). Synthesis of triphenylphosphonium vitamin E derivatives as mitochondria-targeted antioxidants. Tetrahedron 71: 8444&#x2013;8453, https://doi.org/10.1016/j.tet.2015.09.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tet.2015.09.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato, S., Takikawa, M., Nakashima, K., Hirano, A., Cleveland, D.W., Kusaka, H., Shibata, N., Kato, M., Nakano, I., and Ohama, E. (2000). New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: inclusions containing SOD1 in neurons and astrocytes. Amyotroph. Lateral Scler. Other Motor Neuron Disorders 1: 163&#x2013;184, https://doi.org/10.1080/14660820050515160 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820050515160</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi, H., Almer, G., Yamashita, S., Gu&#xe9;gan, C., Nagai, M., Xu, Z., Sosunov, A.A., McKhann, G.M., and Przedborski, S. (2006). Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc. Natl. Acad. Sci. U. S. A. 103: 6025&#x2013;6030, https://doi.org/10.1073/pnas.0509227103 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0509227103</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitakaze, K., Taniuchi, S., Kawano, E., Hamada, Y., Miyake, M., Oyadomari, M., Kojima, H., Kosako, H., Kuribara, T., Yoshida, S., et al.. (2019). Cell-based HTS identifies a chemical chaperone for preventing ER protein aggregation and proteotoxicity. eLife 8: e43302, https://doi.org/10.7554/elife.43302 .</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/elife.43302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolevzon, N., Kuflik, U., Shmuel, M., Benhamron, S., Ringel, I., and Yavin, E. (2011). Multiple triphenylphosphonium cations as a platform for the delivery of a pro-apoptotic peptide. Pharm. Res. 28: 2780&#x2013;2789, https://doi.org/10.1007/s11095-011-0494-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11095-011-0494-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang, L., Kurnik, M., Danielsson, J., and Oliveberg, M. (2012). Fibrillation precursor of superoxide dismutase 1 revealed by gradual tuning of the protein-folding equilibrium. Proc. Natl. Acad. Sci. U. S. A. 109: 17868&#x2013;17873, https://doi.org/10.1073/pnas.1201795109 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1201795109</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang, L., Zetterstr&#xf6;m, P., Br&#xe4;nnstr&#xf6;m, T., Marklund, S.L., Danielsson, J., and Oliveberg, M. (2015). SOD1 aggregation in ALS mice shows simplistic test tube behavior. Proc. Natl. Acad. Sci. U. S. A. 112: 9878&#x2013;9883, https://doi.org/10.1073/pnas.1503328112 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1503328112</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindberg, M.J., Bystr&#xf6;m, R., Bokn&#xe4;s, N., Andersen, P.M., and Oliveberg, M. (2005). Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants. Proc. Natl. Acad. Sci. U. S. A. 102: 9754&#x2013;9759, https://doi.org/10.1073/pnas.0501957102 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0501957102</ArticleId></ArticleIdList></Reference><Reference><Citation>Linhananta, A., Hadizadeh, S., and Plotkin, S.S. (2011). An effective solvent theory connecting the underlying mechanisms of osmolytes and denaturants for protein stability. Biophys. J. 100: 459&#x2013;468, https://doi.org/10.1016/j.bpj.2010.11.087 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2010.11.087</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9;, J., Hervias, I., Henning, M.S., Damiano, M., Kawamata, H., and Manfredi, G. (2009). Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Hum. Mol. Genet. 18: 4552&#x2013;4564, https://doi.org/10.1093/hmg/ddp421 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp421</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik, R., Meng, H., Wongkongkathep, P., Corrales, C.I., Sepanj, N., Atlasi, R.S., Kl&#xe4;rner, F.-G., Schrader, T., Spencer, M.J., Loo, J.A., et al.. (2019). The molecular tweezer CLR01 inhibits aberrant superoxide dismutase 1 (SOD1) self-assembly in&#xa0;vitro and in the G93A-SOD1 mouse model of ALS. J.&#xa0;Biol. Chem. 294: 3501&#x2013;3513, https://doi.org/10.1074/jbc.ra118.005940 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.ra118.005940</ArticleId></ArticleIdList></Reference><Reference><Citation>Nawrocki, G., Im, W., Sugita, Y., and Feig, M. (2019). Clustering and dynamics of crowded proteins near membranes and their influence on membrane bending. Proc. Natl. Acad. Sci. U. S. A. 116: 24562&#x2013;24567, https://doi.org/10.1073/pnas.1910771116 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1910771116</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishitoh, H., Kadowaki, H., Nagai, A., Maruyama, T., Yokota, T., Fukutomi, H., Noguchi, T., Matsuzawa, A., Takeda, K., and Ichijo, H. (2008). ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 22: 1451&#x2013;1464, https://doi.org/10.1101/gad.1640108 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1640108</ArticleId></ArticleIdList></Reference><Reference><Citation>Novoselov, S.S., Mustill, W.J., Gray, A.L., Dick, J.R., Kanuga, N., Kalmar, B., Greensmith, L., and Cheetham, M.E. (2013). Molecular chaperone mediated late-stage neuroprotection in the SOD1G93A mouse model of amyotrophic lateral sclerosis. PLoS One 8: e73944, https://doi.org/10.1371/journal.pone.0073944 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohi, T., Nabeshima, K., Kato, S., Yazawa, S., and Takechi, S. (2004). Familial amyotrophic lateral sclerosis with His46Arg mutation in Cu/Zn superoxide dismutase presenting characteristic clinical features and Lewy body-like hyaline inclusions. J.&#xa0;Neurol. Sci. 225: 19&#x2013;25, https://doi.org/10.1016/j.jns.2004.06.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2004.06.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Olenych, S.G., Claxton, N.S., Ottenberg, G.K., and Davidson, M.W. (2007). The fluorescent protein color palette. Curr. Protoc. Cell Biol. 36: 21.5.1&#x2013;21.5.34, https://doi.org/10.1002/0471143030.cb2105s33 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471143030.cb2105s33</ArticleId></ArticleIdList></Reference><Reference><Citation>Par&#xe9;, B., Lehmann, M., Beaudin, M., Nordstr&#xf6;m, U., Saikali, S., Julien, J.-P., Gilthorpe, J.D., Marklund, S.L., Cashman, N.R., Andersen, P.M., et al.. (2018). Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Sci. Rep. 8: 14223, https://doi.org/10.1038/s41598-018-31773-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlmutter, D.H. (2002). Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking. Pediatr. Res. 52: 832&#x2013;836, https://doi.org/10.1203/00006450-200212000-00004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/00006450-200212000-00004</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky, E., McAlary, L., Farrawell, N.E., Zhao, B., Sher, M., Yerbury, J.J., and Cashman, N.R. (2018). Tryptophan 32-mediated SOD1 aggregation is attenuated by pyrimidine-like compounds in living cells. Sci. Rep. 8: 15590, https://doi.org/10.1038/s41598-018-32835-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-32835-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Politi, R. and Harries, D. (2010). Enthalpically driven peptide stabilization by protective osmolytes. Chem. Commun. 46: 6449, https://doi.org/10.1039/c0cc01763a .</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c0cc01763a</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratnaparkhi, G.S. and Varadarajan, R. (2001). Osmolytes stabilize ribonuclease S by stabilizing its fragments S protein and S peptide to compact folding-competent states. J.&#xa0;Biol. Chem. 276: 28789&#x2013;28798, https://doi.org/10.1074/jbc.m101906200 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.m101906200</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O&#x2019;Regan, J.P., Deng, H.-X., et al.. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59&#x2013;62, https://doi.org/10.1038/362059a0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon, R.A., Bunton-Stasyshyn, R.K.A., Fisher, E.M.C., and Fratta, P. (2013). Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain 136: 2342&#x2013;2358, https://doi.org/10.1093/brain/awt097 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt097</ArticleId></ArticleIdList></Reference><Reference><Citation>Samanta, N., Ribeiro, S.S., Becker, M., Laborie, E., Pollak, R., Timr, S., Sterpone, F., and Ebbinghaus, S. (2021). Sequestration of proteins in stress granules relies on the in-cell but not the in&#xa0;vitro folding stability. J.&#xa0;Am. Chem. Soc. 143: 19909&#x2013;19918, https://doi.org/10.1021/jacs.1c09589 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.1c09589</ArticleId></ArticleIdList></Reference><Reference><Citation>Samanta, N., Ruiz-Blanco, Y.B., Fetahaj, Z., Gnutt, D., Lantz, C., Loo, J.A., Sanchez-Garcia, E., and Ebbinghaus, S. (2022). Superoxide dismutase 1 folding stability as a target for molecular tweezers in SOD1-related amyotrophic lateral sclerosis. ChemBioChem 23: e202200396, https://doi.org/10.1002/cbic.202200396 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbic.202200396</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangwan, S., Zhao, A., Adams, K.L., Jayson, C.K., Sawaya, M.R., Guenther, E.L., Pan, A.C., Ngo, J., Moore, D.M., Soriaga, A.B., et al.. (2017). Atomic structure of a toxic, oligomeric segment of SOD1 linked to amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. U. S. A. 114: 8770&#x2013;8775, https://doi.org/10.1073/pnas.1705091114 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1705091114</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapir, L. and Harries, D. (2015). Macromolecular stabilization by excluded cosolutes: mean field theory of crowded solutions. J.&#xa0;Chem. Theory Comput. 11: 3478&#x2013;3490, https://doi.org/10.1021/acs.jctc.5b00258 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.5b00258</ArticleId></ArticleIdList></Reference><Reference><Citation>Senske, M., Constantinescu-Aruxandei, D., Havenith, M., Herrmann, C., Weing&#xe4;rtner, H., and Ebbinghaus, S. (2016). The temperature dependence of the Hofmeister series: thermodynamic fingerprints of cosolute&#x2013;protein interactions. Phys. Chem. Chem. Phys. 18: 29698&#x2013;29708, https://doi.org/10.1039/c6cp05080h .</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c6cp05080h</ArticleId></ArticleIdList></Reference><Reference><Citation>Senske, M., T&#xf6;rk, L., Born, B., Havenith, M., Herrmann, C., and Ebbinghaus, S. (2014). Protein stabilization by macromolecular crowding through enthalpy rather than entropy. J.&#xa0;Am. Chem. Soc. 136: 9036&#x2013;9041, https://doi.org/10.1021/ja503205y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja503205y</ArticleId></ArticleIdList></Reference><Reference><Citation>Stadmiller, S.S., Gorensek-Benitez, A.H., Guseman, A.J., and Pielak, G.J. (2017). Osmotic shock induced protein destabilization in living cells and its reversal by glycine betaine. J.&#xa0;Mol. Biol. 429: 1155&#x2013;1161, https://doi.org/10.1016/j.jmb.2017.03.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2017.03.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Street, T.O., Bolen, D.W., and Rose, G.D. (2006). A molecular mechanism for osmolyte-induced protein stability. Proc. Natl. Acad. Sci. U. S. A. 103: 13997&#x2013;14002, https://doi.org/10.1073/pnas.0606236103 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0606236103</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai, J., Dave, K., Hahn, V., Guzman, I., and Gruebele, M. (2016). Subcellular modulation of protein VlsE stability and folding kinetics. FEBS Lett. 590: 1409&#x2013;1416, https://doi.org/10.1002/1873-3468.12193 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12193</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandan, R. and Bradley, W.G. (1985). Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Ann. Neurol. 18: 271&#x2013;280, https://doi.org/10.1002/ana.410180302 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410180302</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist, B.G., Hilton, J.B., Hare, D.J., Crouch, P.J., and Double, K.L. (2021). Superoxide dismutase 1 in health and disease: how a frontline antioxidant becomes neurotoxic. Angew. Chem. Int. Ed. 60: 9215&#x2013;9246, https://doi.org/10.1002/anie.202000451 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202000451</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassall, K.A., Stubbs, H.R., Primmer, H.A., Tong, M.S., Sullivan, S.M., Sobering, R., Srinivasan, S., Briere, L.-A.K., Dunn, S.D., Col&#xf3;n, W., et al.. (2011). Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS. Proc. Natl. Acad. Sci. U. S. A. 108: 2210&#x2013;2215, https://doi.org/10.1073/pnas.0913021108 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0913021108</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo, T.-G., Yoon, M.-H., Kang, S., Park, S., Cho, J.-H., Hwang, Y.J., Ahn, J., Jang, H., Shin, Y.-J., Jung, E.-M., et al.. (2021). Novel chemical inhibitor against SOD1 misfolding and aggregation protects neuron-loss and ameliorates disease symptoms in ALS mouse model. Commun. Biol. 4: 1&#x2013;12, https://doi.org/10.1038/s42003-021-02862-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02862-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, X., Xu, Y., Gu, Y., and Sun, M. (2021). 4-Phenylbutyric acid protects islet &#x3b2; cell against cellular damage induced by glucocorticoids. Mol. Biol. Rep. 48: 1659&#x2013;1665, https://doi.org/10.1007/s11033-021-06211-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-021-06211-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., and Kalyanaraman, B. (2017). Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications. Chem. Rev. 117: 10043&#x2013;10120, https://doi.org/10.1021/acs.chemrev.7b00042 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.7b00042</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>